Literature DB >> 6769716

Clomiphene treatment of the idiopathic hypofertile male: high-dose, alternate-day therapy.

L S Ross, G L Kandel, L M Prinz, F Auletta.   

Abstract

Increasing reports suggest that clomiphene citrate (clomid) is useful in the treatment of idiopathic hypofertile males. Recent studies have advocated low-dose, cyclic therapy (25 mg daily for 25 days, 5 days' rest) and, although significant clinical responses have been reported, the hormone response has been erratic. This study of 53 patients, given high-dose, alternate-day therapy (100 mg three times/week), shows an over-all positive response rate of 66% and a pregnancy rate of 26%. Significant gonadotropin and testosterone surges were seen in the responders, but a selective lack of a follicle-stimulating hormone surge was noted in a small group of nonresponders. Clomiphene given in this dosage seems to be safe for periods of up to 15 months and appears to be a rational and useful agent for the treatment of this patient group.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6769716     DOI: 10.1016/s0015-0282(16)44775-8

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

Review 1.  Diagnosis and treatment of infertility-related male hormonal dysfunction.

Authors:  Martin Kathrins; Craig Niederberger
Journal:  Nat Rev Urol       Date:  2016-04-19       Impact factor: 14.432

Review 2.  Hormone-Based Treatments in Subfertile Males.

Authors:  Darshan P Patel; Jason C Chandrapal; James M Hotaling
Journal:  Curr Urol Rep       Date:  2016-08       Impact factor: 3.092

Review 3.  Effectiveness of Clomiphene Citrate for Improving Sperm Concentration: A Literature Review and Meta-Analysis.

Authors:  Dragos Puia; Catalin Pricop
Journal:  Cureus       Date:  2022-05-18

Review 4.  Frontiers in hormone therapy for male infertility.

Authors:  Iyad Khourdaji; Haerin Lee; Ryan P Smith
Journal:  Transl Androl Urol       Date:  2018-07

Review 5.  Current medical management of endocrine-related male infertility.

Authors:  Joshua D Ring; Aye A Lwin; Tobias S Köhler
Journal:  Asian J Androl       Date:  2016 May-Jun       Impact factor: 3.285

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.